CVS Health (NYSE:CVS) PT Raised to $120.00

CVS Health (NYSE:CVSGet Rating) had its price objective increased by Mizuho from $115.00 to $120.00 in a report published on Monday, The Fly reports. The firm currently has a buy rating on the pharmacy operator’s stock.

A number of other equities research analysts have also issued reports on CVS. Credit Suisse Group increased their price target on CVS Health from $113.00 to $117.00 and gave the stock an outperform rating in a research note on Monday, August 8th. Loop Capital started coverage on shares of CVS Health in a report on Thursday, June 16th. They set a buy rating and a $120.00 price objective for the company. UBS Group increased their price objective on shares of CVS Health from $118.00 to $127.00 and gave the company a buy rating in a report on Thursday, August 4th. Sanford C. Bernstein downgraded shares of CVS Health from an outperform rating to a market perform rating and dropped their price objective for the company from $122.00 to $112.00 in a report on Thursday, May 26th. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on shares of CVS Health from $113.00 to $120.00 in a report on Thursday, August 4th. Four equities research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of Moderate Buy and a consensus price target of $117.24.

CVS Health Trading Down 1.2 %

Shares of CVS stock opened at $103.64 on Monday. CVS Health has a 52-week low of $81.78 and a 52-week high of $111.25. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.65 and a current ratio of 0.91. The firm has a market capitalization of $136.06 billion, a PE ratio of 16.85, a PEG ratio of 1.62 and a beta of 0.75. The stock has a fifty day simple moving average of $95.96 and a two-hundred day simple moving average of $99.93.

CVS Health (NYSE:CVSGet Rating) last issued its quarterly earnings results on Wednesday, August 3rd. The pharmacy operator reported $2.40 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.16 by $0.24. CVS Health had a return on equity of 15.19% and a net margin of 2.65%. The business had revenue of $80.64 billion during the quarter, compared to analyst estimates of $76.38 billion. During the same quarter in the prior year, the business posted $2.42 EPS. CVS Health’s revenue for the quarter was up 11.0% compared to the same quarter last year. On average, analysts predict that CVS Health will post 8.54 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, August 1st. Shareholders of record on Friday, July 22nd were paid a $0.55 dividend. This represents a $2.20 annualized dividend and a yield of 2.12%. The ex-dividend date was Thursday, July 21st. CVS Health’s payout ratio is currently 35.77%.

Insider Transactions at CVS Health

In other news, EVP Thomas M. Moriarty sold 138,654 shares of the firm’s stock in a transaction that occurred on Tuesday, June 28th. The shares were sold at an average price of $95.00, for a total transaction of $13,172,130.00. Following the transaction, the executive vice president now directly owns 626,273 shares of the company’s stock, valued at $59,495,935. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other news, EVP Thomas M. Moriarty sold 138,654 shares of the firm’s stock in a transaction that occurred on Tuesday, June 28th. The shares were sold at an average price of $95.00, for a total transaction of $13,172,130.00. Following the transaction, the executive vice president now directly owns 626,273 shares of the company’s stock, valued at $59,495,935. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, EVP Alan Lotvin sold 22,541 shares of the firm’s stock in a transaction that occurred on Thursday, August 4th. The stock was sold at an average price of $104.00, for a total transaction of $2,344,264.00. Following the transaction, the executive vice president now directly owns 109,183 shares in the company, valued at $11,355,032. The disclosure for this sale can be found here. Corporate insiders own 0.69% of the company’s stock.

Hedge Funds Weigh In On CVS Health

Institutional investors have recently bought and sold shares of the business. West Bancorporation Inc. purchased a new position in CVS Health during the fourth quarter valued at approximately $25,000. Macroview Investment Management LLC lifted its stake in shares of CVS Health by 128.3% during the first quarter. Macroview Investment Management LLC now owns 242 shares of the pharmacy operator’s stock worth $25,000 after buying an additional 136 shares during the period. Claremont Financial Group Inc. acquired a new stake in shares of CVS Health during the fourth quarter worth $26,000. Stuart Chaussee & Associates Inc. lifted its stake in shares of CVS Health by 123.0% during the first quarter. Stuart Chaussee & Associates Inc. now owns 310 shares of the pharmacy operator’s stock worth $31,000 after buying an additional 171 shares during the period. Finally, Capital Advisors Ltd. LLC lifted its stake in shares of CVS Health by 125.7% during the fourth quarter. Capital Advisors Ltd. LLC now owns 316 shares of the pharmacy operator’s stock worth $33,000 after buying an additional 176 shares during the period. 78.00% of the stock is owned by hedge funds and other institutional investors.

About CVS Health

(Get Rating)

CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates.

See Also

The Fly logo

Analyst Recommendations for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.